Paroxetine and Permethrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paroxetine (paroxetine hydrochloride) and Permethrin (permethrin). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Paroxetine and Permethrin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Paroxetine?

Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 65,088 Paroxetine users. Check the latest studies of Paroxetine.

What is Permethrin?

Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.



On Aug, 04, 2026

18 people who take Paroxetine and Permethrin together, and have interactions are studied.

Paroxetine and Permethrin drug interactions.

What are the common drug interactions of Paroxetine and Permethrin, by gender? *:

female:

  1. Chronic kidney disease
  2. Drug exposure during pregnancy
  3. Pregnancy with injectable contraceptive
  4. Renal failure (kidney dysfunction)
  5. Drug ineffective
  6. Maternal exposure during pregnancy (use of substance during pregnancy)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Death
  9. Emotional distress
  10. Kidney infection

male:

  1. Chronic kidney disease
  2. Emotional distress
  3. Injection site rash
  4. Nephrolithiasis (calculi in the kidneys)
  5. Renal impairment (severely reduced kidney function)
  6. Fatigue (feeling of tiredness)
  7. Pain
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Decreased activity
  10. Quality of life decreased

What are the common drug interactions of Paroxetine and Permethrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug exposure during pregnancy
  2. Pregnancy with injectable contraceptive
  3. Drug ineffective
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Live birth
  6. Acarodermatitis (skin inflammation caused by mites (acarids))

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Chronic kidney disease
  3. Emotional distress
  4. Kidney infection
  5. Nephrolithiasis (calculi in the kidneys)
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Pain
  8. Renal failure (kidney dysfunction)
  9. Tooth loss
  10. Urinary tract infection

40-49:

  1. Chronic kidney disease
  2. Dizziness
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Pain
  7. Renal impairment (severely reduced kidney function)

50-59:

n/a

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Death
  5. Decreased activity
  6. Emotional distress
  7. Fatigue (feeling of tiredness)
  8. Pain
  9. Quality of life decreased
  10. Renal injury (kidney injury)

What are the existing conditions these people have? *

  1. Acarodermatitis (skin inflammation caused by mites (acarids)): 7 people, 38.89%
  2. Urinary Tract Infection: 7 people, 38.89%
  3. Birth Control: 7 people, 38.89%
  4. Seasonal Allergy (allergic condition due to certain season): 6 people, 33.33%
  5. Hiv Infection: 5 people, 27.78%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  7. Pain: 2 people, 11.11%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
  9. Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places): 1 person, 5.56%
  10. Constipation: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Paroxetine and Permethrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paroxetine and Permethrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paroxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Permethrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paroxetine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Permethrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride and permethrin (the active ingredients of Paroxetine and Permethrin, respectively), and Paroxetine and Permethrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: